Basf Aktiengesellschaft

Abbott Gmbh & Co Kg

Abbott Laboratories Corporation

Basf Se Corporation

Reinhard, Robert

Hamprecht, Gerhard

Puhl, Michael

Seitz, Werner

Werner Seitz

Helmut Mack

Wilfried Hornberger

Gerhard Hamprecht

Robert Reinhard

Thomas Zierke

Thomas Pfeiffer

Michael Puhl

Michael Keil

Bernd Wolf

Stefan Koser

Cyrill Zagar

Udo Lange

Manfred Raschack

Ingo Sagasser

Hans Wolfgang H&ouml;ffken

Alfred Michel

Dorit Baucke

Matthias Witschel

Guido Mayer

Josef Gries

Andreas Landes

Norbert Götz

Verena Baldinger

Hans-Joachim Bohm

Liliane Unger

Andreas Kling

Joachim Gebhardt

Bernd Sievernich

Peter Erk

Gerhard Cox

Hans P Hofmann

Thomas Schmidt

Heidi Emilia Saxell

Horst Kreiskott

Jan Hendrik Wevers

Hans J Treiber

Sandra Löhr

Ferdinand Dengel

Oskar Ehrmann

Hans-Joachim B&ouml;hm

Michael Rack

Andreas Haupt

Dieter Lenke

Liliana Parra Rapado

Norbert Gotz

Heinz Hillen

Herve Geneste

Martin Schmidt

Ulrich Karl

Hans D Lehmann

Claus D Mueller

Hans-Jurgen Teschendorf

Gisela Backfisch

Hans Wolfgang Höffken

Friedhelm Balkenhohl

Ludwig Friedrich

Klaus Groβmann

Arnulf Lauterbach

Martin Traut

Klaus Ruebsamen

Rolf Kretzschmar

Hans-Joerg Treiber

Wolfram Frank

Juergen Delzer

Johann-Christian Zechel

Claudia Isabella Graef

Helmut Schiffer

Klaus Scheib

Hans-Joachim Boehm

Frank Zimmermann

Klaus Ruebsmen

Dirk Wuppermann

Hans-Georg Kurbjuweit

Thomas Subkoski

Annegret Scannell-Lansky

A process for preparing phenyl iso(thio)cyanates of the formula I in which a compound of the formula II or its HCl adduct is reacted with a phosgenating agent where W is oxygen or sulfur and Ar and A are as defined in claimis described. Moreover, the invention relates to the use of the phenyl iso(thio)cyanates for preparing crop protection agents.

Bifunctional phenyl iso(thio)cyanates, processes and intermediates products for their preparation

The present invention relates to a crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)-amino]sulfonyl]benzamide. The invention also relates to a process for the preparation of this crystalline form and to plant protection formulations which comprise this crystalline form of the phenyluracil.

Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methyl-ethyl)amino]sulfonyl]benzamide

The present invention relates to hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]-sulfonyl]benzamide. The invention also relates to a process for the preparation of these hydrates and to plant protection formulations which comprise hydrates of the phenyluracil I.

Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide

Bifunctional phenyl ISO (THIO) cyanates, processes and intermediates for their preparation

Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation

Disclosed are 3-heterocyclyl substituted benzoic acid derivatives of general formula (I), in which the variables Rto Rand X have the meanings indicated in claimand the use thereof as herbicides or for desiccating/defoliating plants.

3-Heterocyclyl substituted benzoic acid derivatives

The invention relates to benzenesulphonamide derivatives of formula (I), methods and intermediate products for production thereof and use of said compounds, or means comprising said compounds for the control of undesired plants and for the desiccation/defoliation of plants.

Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds

A process is described for preparing 3-phenyl(thio)uracils or 3-phenyldithiouracils of the formula I, by reacting a phenyl iso(thio)cyanate of the formula II with an enamine of the formula III and, if appropriate, in a further step, the resulting 3-phenyl(thio)uracil or 3-phenyldithiouracil of the formula I where R=R, when R=hydrogen, is reacted with an aminating agent of the formula IV to give 3-phenyl(thio)uracils or 3-phenyldithiouracils of the formula I where R=amino where the variables R, R, R, R, R, X, X, X, Ar, A and L1 are each as defined in claim

Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils

The invention relates to 1-phenylpyrrolidin-2-one-3-carboxamides of the formula I where the variables R, R, R, X, Y, A, n, R, R, R, Rand Rare as defined in claim 1 and to their agriculturally useful salts. Moreover, the invention relates to

1-phenylpyrrolidine-2-one-3-carboxamides

The invention relates to novel compounds which bind to integrin receptors, their use as ligands of integrin receptors, in particular as ligands of the &#x3b1;&#x3b2;integrin receptor, their use, and pharmaceutical preparations comprising these compounds.

Integrin ligands

The present invention relates to prodrugs of pharmacologically active five-membered heterocyclic amidines from which are produced in vivo compounds which are competitive inhibitors of trypsin-like serine proteases, in particular thrombin and kininogenases such as kallikrein, to the preparation thereof and to the use thereof as medicines. The invention also relates to pharmaceutical compositions which comprise the prodrugs of the active compounds as ingredients, and to the use of the compounds as thrombin inhibitors, anticoagulants and as antiinflammatory agents.

Prodrugs of thrombin inhibitors

The invention relates to a compound of the formula I:or a salt thereof with a physiologically tolerated acid, or stereoisomers thereof, wherein R, R, A, B, C and D have the meanings described in the specification.

Thrombin inhibitors

Novel five-membered heterocyclic amidines, their preparation and use as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein. Pharmaceutical compositions which contain the compounds as active ingredients, and use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory agents.

Peptide substances, their preparation and their use as complement inhibitors are described. These are in particular substances having a guanidine or amidine radical as a terminal group. In particular, inhibitors of the complement proteases C1s and C1r are described.

Low molecular weight inhibitors of complement proteases

Thrombin inhibitors, the preparation and use thereof

Growing community of inventors

Plankstadt, Germany

Werner Seitz